TRDA Competitors & Alternatives
Compare Entrada Therapeutics Inc with similar stocks in the same industry
Biotechnology
TRDA
Main Stock$7.07
Tradestie Score
50
Market Cap
$223.66M
Revenue Growth
-1.0%
Analyst Upside
+165.2%
Top Competitors
220 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ANNX
Annexon, Inc. Common Stock
|
$5.04
|
$332.96M | - | 52 | Compare |
|
REPL
Replimune Group, Inc.
|
$11.18
|
$328.62M | - | 61 | Compare |
|
CADL
Candel Therapeutics, Inc. Common Stock
|
$9.15
|
$304.12M | - | 57 | Compare |
|
JBIO
Jade Biosciences, Inc. Common Stock
|
$19.45
|
$297.23M | - | 52 | Compare |
|
TECX
Tectonic Therapeutic, Inc. Common Stock
|
$30.34
|
$293.03M | - | 59 | Compare |
|
OMER
Omeros Corporation
|
$10.33
|
$281.75M | 9.0 | 56 | Compare |
|
DBVT
DBV Technologies S.A.
|
$15.70
|
$275.54M | - | 56 | Compare |
|
ALLO
Allogene Therapeutics, Inc. Common Stock
|
$2.10
|
$275.13M | - | 59 | Compare |
|
VOR
Vor Biopharma Inc. Common Stock
|
$14.94
|
$269.08M | - | 54 | Compare |
|
VTYX
Ventyx Biosciences, Inc. Common Stock
|
$14.00
|
$256.71M | - | 53 | Compare |
More TRDA Analysis
Data updated: Jun 23, 2026 | Industry: Biotechnology (SIC 2834)
220 stocks in this industry